[The role of diabetes mellitus in cardiac disease in Spain. The CARDIOTENS Study 1999].
| Autor: | Ramón González-Juanatey J; Sección de HTA de la Sociedad Española de Cardiología y Hospital Universitario de Santiago de Compostela. jgonzalezd@meditex.es, Alegría Ezquerra E, María García Acuña J, González Maqueda I, Vicente Lozano J |
|---|---|
| Jazyk: | Spanish; Castilian |
| Zdroj: | Medicina clinica [Med Clin (Barc)] 2001 May 19; Vol. 116 (18), pp. 686-91. |
| DOI: | 10.1016/s0025-7753(01)71953-7 |
| Abstrakt: | Background: We analyse the characteristics of the patients with diabetes and cardiac disease included in the CARDIOTENS 1999 study. Patients and Method: 32,051 outpatients who were seen the same day by 1,159 primary healthcare physicians (79%) and cardiologists (21%) were prospectively registered in a database including demographic and clinical data and therapeutic profile. Results: History of cardiac disease was present in 19% (6,194 patients) of the whole population, and 1,275 of them (20.6%) were diabetics. Hypertension was present in 74% of diabetic patients with cardiac disease. Coronary heart disease (angina pectoris or previous myocardial infarction) was present in 45% of diabetic patients with heart failure. Less than 30% of these patients had blood pressure levels under 130/85 mmHg, as recommended by international guidelines. An LDL-cholesterol level lower than 100 mgrs/dl was observed in only 12% of diabetic patients with coronary heart disease; the mean values of total cholesterol and LDL-cholesterol of these patients were significantly (p < 0.01) higher in those seen by primary healthcare physicians. Less than 40% of diabetic patients with cardiac disease were treated with an angiotensin converting enzyme inhibitor, a therapy which was otherwise used in 50% of diabetic patients with heart failure. A beta-blocker therapy was used in 26% of diabetic patients with coronary heart disease and 39% of them were being treated with statins. Conclusions: More than 20% of patients with cardiac disease in this study were diabetics. Blood pressure and cholesterol levels recommended by current guidelines were attained in a limited proportion of these patients. The use of drugs with demonstrated prognostic benefit in diabetic patients with heart disease is scarce. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|